• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Madison Muller

Stay informed with Madison Muller’s coverage and analysis.

Hims & Hers scraps copycat Wegovy weight-loss pill after probe
North AmericaHims & Hers scraps copycat Wegovy weight-loss pill after probe
By Jessica Nix, Madison Muller and BloombergFebruary 7, 2026
Eli Lilly's headquarters sits behind a gate with the US flag raised
FinanceEli Lilly to spend $27 billion to bolster U.S. drug manufacturing as Trump tariffs loom
By Madison Muller and BloombergFebruary 26, 2025
Semaglutide medications Wegovy and Ozempic are pictured
HealthWegovy, Ozempic shortage declared over, hitting copycats like Hims & Hers
By Bloomberg, Madison Muller, Ike Swetlitz and Naomi KresgeFebruary 21, 2025
A hand is seen holding Ozempic.
HealthNovo’s main Ozempic plant cited for quality lapses by FDA
By Madison Muller and BloombergOctober 29, 2024
Sen. Bernie Sanders is seen pointing and speaking at the opening of a Senate committee hearing.
PoliticsBernie Sanders grills Ozempic maker over high prices, accuses company of endangering lives
By Madison Muller, Naomi Kresge, Riley Griffin and BloombergSeptember 24, 2024
A doctor holds a package of the drug Ozempic. The logo is clearly visible and there is a visual of the product on the box.
FinanceOzempic ‘very likely’ to have price slashed in US government negotiations
By Gerry Smith, Madison Muller and BloombergSeptember 17, 2024
A photo of the packet for anti-obesity drug Wegovy.
HealthWegovy reduced Covid deaths in obese patients, study finds
By Madison Muller and BloombergAugust 30, 2024
Lilly wins FDA approval for new drug to slow Alzheimer’s
HealthLilly wins FDA approval for new drug to slow Alzheimer’s
By Madison Muller, Robert Langreth and BloombergJuly 2, 2024
woman shows off old oversized jeans
HealthHims will follow its Viagra playbook and offer weight-loss drugs that are 85% cheaper than Wegovy—with Mounjaro and Zepbound in its sights next
By Madison Muller, Jessica Nix and BloombergMay 20, 2024
Demand for weight-loss drug Zepbound is so strong that Eli Lilly is warning patients may leave pharmacies empty-handed 
HealthDemand for weight-loss drug Zepbound is so strong that Eli Lilly is warning patients may leave pharmacies empty-handed 
By Ike Swetlitz, Madison Muller and BloombergMarch 30, 2024
Bernie Sanders
Politics‘Outrageous’: Bernie Sanders has Ozempic demands after study says it costs just $5 per month to manufacture
By Madison Muller, Robert Langreth and BloombergMarch 28, 2024
Ozempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5
HealthOzempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5
By Madison Muller, Robert Langreth and BloombergMarch 28, 2024
A man walking in front of Sweetgreen
RetailMeet the surprise winner of the Ozempic craze: a fast-casual chain selling $18 salads
By Madison Muller and BloombergFebruary 21, 2024
Patients given a monthly injection of Amgen’s drug, dubbed MariTide, lost up to 14.5% of their body weight in just 12 weeks, according to a small, early-stage study published Monday in the journal Nature Metabolism.
HealthExperimental once-a-month weight loss injectable shows lasting results in early study
By Madison Muller and BloombergFebruary 5, 2024
The last time there was this much hype over a new drug was for Viagra, which was approved in 1998. Yet hurdles remain, when it comes to the ability of patients to access weight loss and anti-diabetes injectables like Zepbound and Wegovy: These drugs cost a lot, insurance coverage is spotty, and patients may need to take them indefinitely to avoid regaining weight.
HealthWeight-loss injectables like Zepbound are making as big of a splash as Viagra, if not bigger. What you need to know about the ‘miracle drugs’
By Emma Court, Madison Muller and BloombergJanuary 31, 2024
1
  • 1
  • 2
  • 3
3
Most Popular
Politics
The Bezos family just donated $100 million to help achieve one of Mayor Zohran Mamdani’s top campaign promisesplaceholder alt text
By Jake AngeloMay 12, 2026
AI
Microsoft AI chief gives it 18 months—for all white-collar work to be automated by AIplaceholder alt text
By Jake AngeloMay 16, 2026
Economy
While Trump insisted the Iran war would end ‘soon,’ an account in his name was buying millions in oil, defense and goldplaceholder alt text
By Eva RoytburgMay 18, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.